FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
BIAXIN
clarithromycin
LOE Approaching
AbbVie
ORAL · TABLET
mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditionsGranules for Oral Suspension) Pharyngitis/Tonsillitis due to Streptococcus pyogenes (The usual drug of choice in the treatment+13
1991
NDA30/100
BIAXIN XL
clarithromycin
LOE Approaching
AbbVie
ORAL · TABLET
mild to moderate infections caused by susceptible isolates due to Haemophilus influenzaeMoraxella catarrhalis+12
1993
NDA30/100
BIAXIN XL
clarithromycin
LOE Approaching
AbbVie
ORAL · TABLET, EXTENDED RELEASE
mild to moderate infections caused by susceptible isolates due to Haemophilus influenzaeMoraxella catarrhalis+12
2000
NDA30/100
BICILLIN
penicillin g benzathine
LOE Approaching
Thayer Medical
ORAL · SUSPENSION
the treatment of infections due to penicillin-G-sensitive microorganismsvery prolonged serum levels common to this particular dosage form
1951
NDA30/100
BICILLIN C-R
penicillin g benzathine and penicillin g procaine
LOE Approaching
Pfizer
INJECTION · INJECTABLE
the treatment of infectionsthe treatment of the following in pediatric patients: Moderately severe to severe infections of the upper-respiratory tract+4
1953
NDA30/100
BICILLIN C-R 900/300
penicillin g benzathine and penicillin g procaine
LOE Approaching
Pfizer
INJECTION · INJECTABLE
the treatment of infectionsthe treatment of the following in pediatric patients: Moderately severe to severe infections of the upper-respiratory tract+4
1953
NDA30/100
BICILLIN L-A
penicillin g benzathine
LOE Approaching
Thayer Medical
INJECTION · INJECTABLE
the treatment of infections due to penicillin-G-sensitive microorganismsvery prolonged serum levels common to this particular dosage form
1958
NDA30/100
BICILLIN L-A
penicillin g benzathine
LOE Approaching
Pfizer
INJECTION · INJECTABLE
the treatment of infections due to penicillin-G-sensitive microorganismsvery prolonged serum levels common to this particular dosage form
1952
NDA30/100
BICNU
carmustine
LOE Approaching
INJECTION · INJECTABLE
glioblastomamyeloma+1
1977
NDA30/100
BIDIL
hydralazine hydrochloride and isosorbide dinitrate
LOE Approaching
R-Pharm US
ORAL · TABLET
heart failureto prolong time to hospitalization for heart failure+1
2005
NDA30/100
BILOPAQUE
tyropanoate sodium
LOE Approaching
ORAL · CAPSULE
1969
NDA30/100
BILTRICIDE
praziquantel
LOE Approaching
Bayer
ORAL · TABLET
older for the treatment of the following infections: • Schistosomiasis due to all species of schistosoma (for exampleSchistosoma mekongi+7
1982
NDA30/100
BIORPHEN
phenylephrine hydrochloride
Peak
Dr. Reddy's Laboratories
INTRAVENOUS · SOLUTION
clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia
2019
NDA30/100
BIOSCRUB
chlorhexidine gluconate
LOE Approaching
TOPICAL · SPONGE
1989
NDA30/100
BIPHETAMINE 12.5
amphetamine resin complex; dextroamphetamine resin complex
LOE Approaching
UCB Pharma
ORAL · CAPSULE, EXTENDED RELEASE
1955
NDA30/100
BIPHETAMINE 20
amphetamine resin complex; dextroamphetamine resin complex
LOE Approaching
UCB Pharma
ORAL · CAPSULE, EXTENDED RELEASE
1955
NDA30/100
BIPHETAMINE 7.5
amphetamine resin complex; dextroamphetamine resin complex
LOE Approaching
UCB Pharma
ORAL · CAPSULE, EXTENDED RELEASE
1955
NDA30/100
BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
bivalirudin
Peak
Baxter
INTRAVENOUS · SOLUTION
2017
NDA30/100
BLENOXANE
bleomycin sulfate
LOE Approaching
Bristol Myers Squibb
INJECTION · INJECTABLE
Lymphoma
1973
NDA30/100
BLEPHAMIDE
prednisolone acetate; sulfacetamide sodium
LOE Approaching
AbbVie
OPHTHALMIC · SUSPENSION
inflammatory conditions of the palpebralbulbar conjunctiva+8
1961
NDA30/100
BLOCADREN
timolol maleate
LOE Approaching
Merck & Co.
ORAL · TABLET
elevated intraocular pressure (IOP) in patients with open-angle glaucomaocular hypertension+2
1981
NDA30/100
BLOXIVERZ
neostigmine methylsulfate
Peak
INTRAVENOUS · SOLUTION
2013
NDA30/100
BONIVA
ibandronate sodium
LOE Approaching
Roche
ORAL · TABLET
osteoporosis
2003
NDA30/100
BONIVA
ibandronate sodium
LOE Approaching
Roche
INTRAVENOUS · INJECTABLE
osteoporosis
2006
NDA30/100